ResMed addresses takeover rumours
Tuesday, 01 July, 2008
ResMed (ASX:RMD) responded today to reports in The Age and Australian Financial Review newspapers of a rumoured takeover bid by Germany's Linde Group.
In a statement to the stock exchange, ResMed said it had a policy of not commenting on market rumours, but also told the ASX the company was not aware of any information it was required to disclose to the market.
ResMed's disclosure follows reports in The Age of rumours that the company "is being stalked by industrial and medical gas giants the Linde Group", and in the Australian Financial Review referring to "rumours of an agreed cash bid". Both reports were published today.
Organoid platform enables closer study of bat-borne viruses
Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...
Global study finds 250 genes linked to OCD
Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
